Article info

Original research
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

Authors

  1. Correspondence to Professor I Jolanda M de Vries; jolanda.devries{at}radboudumc.nl
View Full Text

Citation

van der Woude LL, Gorris MAJ, Wortel IMN, et al
Tumor microenvironment shows an immunological abscopal effect in patients with NSCLC treated with pembrolizumab-radiotherapy combination

Publication history

  • Accepted September 17, 2022
  • First published October 17, 2022.
Online issue publication 
December 07, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.